Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Aphria Inc. Receives EU GMP Certification for Aphria One Facility

PR Newswire January 22, 2020

Aphria Inc. Receives EU GMP Certification for Aphria One Facility

Canada NewsWire January 22, 2020

2 Aphria cultivation facilities receive EU-GMP certification

Stockhouse Editorial January 21, 2020

Aphria Inc. Receives EU GMP Certification for Subsidiary ARA-Avanti Rx Analytics

Canada NewsWire January 21, 2020

The Cannabis Comeback Has Started

Omri Wallach January 20, 2020

U.S. Markets Shuttered for Holiday

Livemoney January 20, 2020

The StockTalk Cannabis Report: Jan. 17, 2020

Dave Jackson January 17, 2020

Aphria Inc. Launches Plant Positivity Immersive Winter Garden to Help Combat Winter Blues

PR Newswire January 16, 2020

Aphria Inc. Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter

Canada NewsWire January 14, 2020

The StockTalk Cannabis Report: Jan. 10, 2020

Dave Jackson January 10, 2020

Aphria Inc. to Participate in the 2020 ICR Conference

Canada NewsWire January 7, 2020

Aphria Inc. to Announce Second Quarter Fiscal 2020 Financial Results on January 14, 2020

Canada NewsWire December 30, 2019

The Cannabis Moneymaker: Friday the 13th!

Dave Jackson December 13, 2019

Stockhouse Suggests Some Holiday Bargain Stocks

Jonathon Brown December 9, 2019

Aphria Inc. Announces $80 Million Financing Of Aphria Diamond

Canada NewsWire December 2, 2019

View from the C-Suite: Carl Mertin, Chief Financial Officer, Aphria Inc., tells his company's story. Filmed on October 16, 2019

Canada NewsWire November 20, 2019

Investor Ideas Cannabis Potcasts Releases Insight from Thought Leaders on the Cannabis Market in North America and Globally

Newsfile November 20, 2019

Aphria Inc. Announces Election of Board of Directors and Executive Appointments and Promotions

Canada NewsWire November 15, 2019

Aphria Inc. Brands Win Top Honours at 2019 Canadian Cannabis Awards

Canada NewsWire November 11, 2019

Aphria Inc. to Participate in Jefferies West Coast Consumer Conference

Canada NewsWire November 7, 2019